BioSpace News Archive

Business

GSK Funds a New Startup with Immunometabolic Focus

A new biopharmaceutical company known as Sitryx launched with $30 million in a Series A funding round to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation.

October 8, 2018
·
2 min read
·
Alex Keown
Business

Can AI Detect Parkinson’s Disease from a Video? Tencent and Medopad Team up to Find Out

Medopad, a U.K.-based medical firm, and China-based Tencent Holdings, have teamed up on a project that will attempt to harness artificial intelligence in the diagnosis of Parkinson’s disease.

October 8, 2018
·
2 min read
·
Alex Keown
Talking Too Much! How to Handle the Office Gossip

Being the target of gossip in the workplace can negatively affect your reputation, character, and promotional opportunities. Here are four keys to working with the office gossip.

October 8, 2018
·
3 min read
·
Porschia Parker
Policy

A Test for Opioid Lawsuits, Ohio Case Is Pushed Forward by Magistrate

Opioid manufacturers have been the target of thousands of lawsuits from state and local governments seeking to reclaim funds that have been spent on addressing treatment for opioid abuse and overdoses.

October 8, 2018
·
2 min read
·
Alex Keown
BioCapital

Study Shows Drugs on FDA Shortage List Are Likely to See Price Hikes

A study published in the Annals of Internal Medicine highlights some of the problems that drug shortages bring to the healthcare system, including a rise in prices. The research, as highlighted by Business Insider, examined the prices of 917 drugs that were in shortage between 2015 and 2016.

October 8, 2018
·
3 min read
·
Alex Keown
Business

Nobel Prizes Underscore Benefits of Research, but Also Highlight ‘Worst Instincts’ of Industry: Report

In a report, Bloomberg said that pharma’s “efforts to maximize (financial) gains” has led to the coloring of R&D decisions and creating barriers to the entry of competing medications that can add costs to the health care system.

October 8, 2018
·
2 min read
·
Alex Keown
Drug Development

Akcea Therapeutics and Ionis Pharmaceuticals Snag FDA Approval for Tegsedi

The U.S. Food and Drug Administration gave Akcea Therapeutics and its parent company Ionis Pharmaceuticals the green light for Tegsedi, its treatment for polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.

October 8, 2018
·
3 min read
·
Alex Keown
Policy

Novartis on the Fast Track for Potential FDA Approval of MS Drug

Swiss pharma giant Novartis could be on its way to securing regulatory approval for its secondary progressive multiple sclerosis (SPMS) treatment siponimod.

October 8, 2018
·
2 min read
·
Alex Keown
Business

CLSA Names Pantheon DiNA Award Winners

Bristol-Myers Squibb, Nektar Therapeutics, Amgen and others will be recognized for their significant contributions to the California life sciences industry during the November 2018 Pantheon DiNA Awards hosted by the California Life Sciences Association.

October 8, 2018
·
3 min read
·
Alex Keown
East Suffolk and North Essex NHS Foundation Trust Employs Thoughtonomy Virtual Workers Alongside Human Teams to Improve Patient Experience and Boost Employee Satisfaction

Groundbreaking intelligent automation program highlights huge potential for realizing efficiency benefits rapidly across the NHS.

October 8, 2018
·
4 min read